No Result
View All Result
SUBSCRIBE | NO FEES, NO PAYWALLS
MANAGE MY SUBSCRIPTION
NEWSLETTER
Corporate Compliance Insights
  • Home
  • About
    • About CCI
    • CCI Magazine
    • Writing for CCI
    • Career Connection
    • NEW: CCI Press – Book Publishing
    • Advertise With Us
  • Explore Topics
    • See All Articles
    • Compliance
    • Ethics
    • Risk
    • FCPA
    • Governance
    • Fraud
    • Internal Audit
    • HR Compliance
    • Cybersecurity
    • Data Privacy
    • Financial Services
    • Well-Being at Work
    • Leadership and Career
    • Opinion
  • Vendor News
  • Library
    • Download Whitepapers & Reports
    • Download eBooks
    • New: Living Your Best Compliance Life by Mary Shirley
    • New: Ethics and Compliance for Humans by Adam Balfour
    • 2021: Raise Your Game, Not Your Voice by Lentini-Walker & Tschida
    • CCI Press & Compliance Bookshelf
  • Podcasts
    • Great Women in Compliance
    • Unless: The Podcast (Hemma Lomax)
  • Research
  • Webinars
  • Events
  • Subscribe
Jump to a Section
  • At the Office
    • Ethics
    • HR Compliance
    • Leadership & Career
    • Well-Being at Work
  • Compliance & Risk
    • Compliance
    • FCPA
    • Fraud
    • Risk
  • Finserv & Audit
    • Financial Services
    • Internal Audit
  • Governance
    • ESG
    • Getting Governance Right
  • Infosec
    • Cybersecurity
    • Data Privacy
  • Opinion
    • Adam Balfour
    • Jim DeLoach
    • Mary Shirley
    • Yan Tougas
No Result
View All Result
Corporate Compliance Insights
Home Compliance

Top Risks in Supply Chain & Distribution Channels: The Risk of Counterfeit Drugs

Understanding a Key Threat in Pharmaceuticals to Manage Risk Effectively

by Russ Berland
March 25, 2019
in Compliance, Featured
falling tablets and capsules on dark blue background

In part 1 of a series on supply chain risk, Russ Berland begins a discussion addressing supply chain risk: the gaps, the frauds, the disconnects, the counterfeits, the gray market. Consider: to the extent that these are our supply chains, they are someone else’s distribution channel.

A mother in Kenya has a child who is sick with malaria; he is listless and has a high fever. She goes to the local drug market to purchase malaria medicine and gives the medicine to her child, but his fever increases and he dies. The drug she gave him was a counterfeit. If she had had the real drug, his life could have been spared. This situation happens daily, as drug counterfeiters and gray markets infiltrate the pharmaceutical distribution channel and, in this case, this woman’s personal supply chain.

Counterfeit goods are just one risk in supply chains and distribution channels. Besides counterfeit drugs, we see counterfeit athletic and fashion shoes, computers and server parts, consumer electronics, personal care products, wallets, watches and jewelry, food and even automotive parts.[1] Gray market goods are real goods that leave the distribution chain under some reduced pricing program for specific markets – think HIV drugs for Africa – and re-enter a higher-cost market to compete on price. These gray market goods may be spoiled, stored past expiration, adulterated, fail to meet market and local legal requirements and be subject to innumerable other uncontrollable conditions.

How could this mother buy fake malaria drugs in Kenya? According to the World Health Organization, more than 120,000 people die every year using fake anti-malarial drugs. Some have estimated that up to one-third of anti-malarial drugs in sub-Saharan Africa are fake.[2] And these counterfeit drugs are used and sold by clinics, pharmacies, street vendors and online.

We are experiencing these risks in the U.S., as well. For example, after increased visibility into opioid over-prescription and addiction, regulations, doctors and pharmacies are becoming tighter on the control of these medications. This has created an opportunity for criminals to sell “prescription” oxycodone and other opioids, which do not even contain these medications. Instead, they sell pills that are molded in the shape of oxycodone and other painkillers and dispensed in legitimate-looking pharmacy bottles, but that actually contain a small quantity of fentanyl and filler.[3] Fentanyl is a pain killer that is at least 50 times more powerful than heroin and highly dangerous if used improperly.

Ashley Romero was a 32-year-old mother who had dealt with acute pain from flare-ups of pancreatitis. Her boyfriend obtained a bottle of prescription oxycodone pills from a friend. During a flare-up, while she was cooking eggs and potatoes on the stove, he gave her one of those pills and then he took one himself. They both became disoriented, left the food cooking on the stove and were found unconscious outside their home. EMTs were able to revive the boyfriend, but not Romero. The pills they took actually contained fentanyl, not oxycodone, and they both experienced symptoms of fentanyl overdose.[4]  Five people have been charged in Romero’s death, including a person who was believed to have made monthly trips to Mexico to obtain the fake oxycodone pills. Fentanyl-laced pills are now widely available on internet pharmacies, often labeled as “Canadian” pharmacies, in legitimate-looking prescription pain pills labeled as hydrocodone, oxycodone and other pain relievers.[5] These fentanyl-laced pills are being found globally; in some cases, they are sold by smaller pharmacies believing they are buying legitimate medicine from a lower-cost source, such as the gray market.

In other industries, manufacturers are buying counterfeit batteries and chargers, leading to underperformance and even fires. Auto mechanics are buying counterfeit “OEM” replacement parts like air bags, which are substandard and dangerous. Consumers are buying counterfeit products off the internet every few seconds, often not knowing the nature and tangled origin of the goods.

This article has focused on just one subset (pharmaceuticals) of one set (counterfeit and gray-market goods) of supply chain and distribution chain risks. In order to create comprehensive risk management systems for our supply chains and distribution channels, we must understand the risks we face.

As with any good system, we will examine the tools at our disposal, such as risk assessments and analyses, policies, training, communications, internal governance, internal controls, employees’ incentives and discipline, audits, investigations, background data reports on distributors, resellers/vendors and such emerging solutions as big data, artificial intelligence, blockchain and RFID tags. We will examine each aspect of the interlinked domains of supply chain risk management and distribution chain risk management – both the risks and the risk management opportunities.

Stay tuned for the next installment in the series, on risks in food distribution and sourcing.


[1] https://finance.yahoo.com/news/10-most-counterfeited-products-america-100032647.html

[2] https://www.bbc.com/news/business-37470667

[3] https://www.safemedicines.org/wp-content/uploads/2018/08/Fentanyl101-infographic-4p.pdf

[4] https://www.gjsentinel.com/news/western_colorado/a-family-tragedy-a-public-warning/article_14778f8e-744d-11e8-a998-10604b9ffe60.html

[5] https://www.safemedicines.org/2019/02/five-people-charged-over-the-death-of-ashley-romero-from-a-fake-fentanyl-pill.html


Tags: Supply Chain
Previous Post

Brexit, Uncertainty and Values at Risk: 5 Risk Management Lessons

Next Post

4 Privacy Trends Companies Must Consider to Achieve a Competitive Edge

Russ Berland

Russ Berland

Russ Berland is a seasoned leader who creates value in an organization by leading high-performance teams in law, compliance and risk management. He works with innovative, multinational organizations and has achieved measurable and timely results in the areas of law, compliance, strategic planning, international business and risk management. As an engineer and former federal court law clerk, he achieves business objectives and solves problems via deep experience, innovation with sound judgment and effective and efficient management of people, resources and costs. Russ is Chief Compliance Officer of Aventiv Technologies in Dallas, Texas.

Related Posts

polluted water

PFAS Reporting Window Delayed, but Waiting to Act on ‘Forever Chemicals’ Could Be Risky

by Cally Edgren
June 9, 2025

Technical issues on government portal give companies short reprieve

supply chain shipping containers

‘You Don’t Want to Be the First Company to Not Comply’: How Trump’s Tariffs Are Shaking Supply Chains

by Cathy Siegner
March 31, 2025

The ripple effects of tariff policies extend far beyond simple cost increases, creating complex compliance challenges that span legal, financial...

news roundup header image papers

Internal Audit Group Prepares New Third-Party Topical Requirement

by Staff and Wire Reports
March 7, 2025

Most organizations expect to increase fraud budgets

mineral mining operation

Why Critical Minerals Demand a Compliance Revolution

by Rebeca Vergara Gaona
February 11, 2025

Corporate compliance lessons could help strengthen intergovernmental mineral agreements before problems arise

Next Post
businessmen pushing blocks with man in lead rolling a ball

4 Privacy Trends Companies Must Consider to Achieve a Competitive Edge

No Result
View All Result

Privacy Policy | AI Policy

Founded in 2010, CCI is the web’s premier global independent news source for compliance, ethics, risk and information security. 

Got a news tip? Get in touch. Want a weekly round-up in your inbox? Sign up for free. No subscription fees, no paywalls. 

Follow Us

Browse Topics:

  • CCI Press
  • Compliance
  • Compliance Podcasts
  • Cybersecurity
  • Data Privacy
  • eBooks Published by CCI
  • Ethics
  • FCPA
  • Featured
  • Financial Services
  • Fraud
  • Governance
  • GRC Vendor News
  • HR Compliance
  • Internal Audit
  • Leadership and Career
  • On Demand Webinars
  • Opinion
  • Research
  • Resource Library
  • Risk
  • Uncategorized
  • Videos
  • Webinars
  • Well-Being
  • Whitepapers

© 2025 Corporate Compliance Insights

Welcome to CCI. This site uses cookies. Please click OK to accept. Privacy Policy
Cookie settingsACCEPT
Manage consent

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
CookieDurationDescription
cookielawinfo-checbox-analytics11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checbox-functional11 monthsThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checbox-others11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-necessary11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-performance11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy11 monthsThe cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
Functional
Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.
Performance
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
Analytics
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
Advertisement
Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
Others
Other uncategorized cookies are those that are being analyzed and have not been classified into a category as yet.
SAVE & ACCEPT
No Result
View All Result
  • Home
  • About
    • About CCI
    • CCI Magazine
    • Writing for CCI
    • Career Connection
    • NEW: CCI Press – Book Publishing
    • Advertise With Us
  • Explore Topics
    • See All Articles
    • Compliance
    • Ethics
    • Risk
    • FCPA
    • Governance
    • Fraud
    • Internal Audit
    • HR Compliance
    • Cybersecurity
    • Data Privacy
    • Financial Services
    • Well-Being at Work
    • Leadership and Career
    • Opinion
  • Vendor News
  • Library
    • Download Whitepapers & Reports
    • Download eBooks
    • New: Living Your Best Compliance Life by Mary Shirley
    • New: Ethics and Compliance for Humans by Adam Balfour
    • 2021: Raise Your Game, Not Your Voice by Lentini-Walker & Tschida
    • CCI Press & Compliance Bookshelf
  • Podcasts
    • Great Women in Compliance
    • Unless: The Podcast (Hemma Lomax)
  • Research
  • Webinars
  • Events
  • Subscribe

© 2025 Corporate Compliance Insights